Timeline
The IGA has reached many milestones since its inception in 1994.
The EGA is founded
The European Gaucher Alliance is founded by patient groups from France, Israel, Italy, the Netherlands, Sweden and the UK
The first EGA meeting is held
The first EGA meeting is held at the EWGGD in Jerusalem attended by 11 patient groups
ECAP is launched
The EGA works with Genzyme to develop and launch the European Cerezyme Access Programme (ECAP), a humanitarian aid programme for patients in Eastern Europe to access life-saving treatment
The EGA becomes a formal organisation
The EGA becomes a formal organisation and a board of directors was elected
European Parliament
The EGA is formally launched in European Parliament
Recognised by the EMA
The EGA receives recognition as a formal patient group by the European Medicines Agency (EMA)
Go With Gaucher is launched
The first Go With Gaucher (GWG) meeting takes place in Frankfurt; a project to take forward the next generation of young Gaucher leaders
EURORDIS membership
The EGA becomes a full member of EURORDIS
International Gaucher Day
International Gaucher Day (IGD) is launched to raise awareness of Gaucher disease
Going global
Members vote to remove the difference between ‘full’ and ‘associate’ members so that all members have equal rights, thus marking the first steps to becoming an international organisation
Multi-stakeholder meeting
The EGA convenes a multi-stakeholder meeting in London, UK to identify the priorities for the global Gaucher community, attended by 17 key opinion leaders
Regional manager programme
The IGA appoints three regional managers to increase its capacity and capability in South Asia and Eastern Europe
EGA becomes the IGA
During the biennial members meeting in Riga, members vote to become the International Gaucher Alliance
Rare Disease International
The IGA becomes a member of RDI
nGD registry
The IGA launches Phase 1 of the development of a global patient registry for neuronopathic Gaucher disease to support a better understanding of the natural history of the disease
Membership grows to 50
The IGA’s membership reaches 50 associations representing 51 countries world-wide
Partnership with Kantar
The IGA enters into a Letter of Intent with Kantar, to manage the day to day running of the IGA’s global neuronopathic Gaucher disease patient registry
Charity status
The IGA is granted Charity status by the Charity Commission of England and Wales and is entered onto the Register of Charities
GARDIAN is launched
The IGA and Kantar Health launch the disease registry GARDIAN: Gaucher Registry for Development Innovation and Analysis of Neuronopathic Disease.


































